News
Rezpeg's promising Phase 2b data makes Nektar Therapeutics a strong contender in the AD market. Click here to read an ...
Epique Realty Deepens Agent-Client Relationships with New Epique Elevate Home Management Platform NASHVILLE, TN / ACCESS ...
Women-centric probiotic products are gaining immense traction due to their specific applications in gut, vaginal, and ...
Nektar Therapeutics stock surged 116% in premarket trading after announcing successful Phase 2b trial results for its atopic dermatitis treatment.
Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces ...
Regeneron remains committed to supporting patient access to medications and believes that patients should be able to access whatever therapy their physician prescribes for them. In the past decade, ...
Chugai Pharma presents positive data from NXTAGE phase I/II study of NXT007 in people with haemophilia A at ISTH 2025 Congress: Tokyo Tuesday, June 24, 2025, 13:00 Hrs [IST] Chuga ...
A new name is reshaping the landscape of skincare and beauty in New Jersey: G Halo Beauty, founded by skincare enthusiast and visionary Erika Pelaez... WARREN, NJ, UNITED STATES, June 19, 2025 ...
The milk mineral concentrate market is projected to reach a valuation of USD 120.1 million in 2025 and is expected to surge ...
13d
Tuko News on MSNList of medical courses with D+ offered in Kenyan collegesChe out medical courses with D+ in Kenya. Read the article to find some of the most marketable medical courses for D+ ...
Girish Ganachari has consistently demonstrated exceptional leadership and innovation in the realm of healthcare data engineering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results